Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
$5.04
+4.6%
$5.56
$2.68
$8.22
$158.78M3.99297,855 shs912,876 shs
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$0.06
-14.5%
$0.07
$0.00
$0.12
$18.29M1.7797,280 shs138,416 shs
Reliv' International, Inc. stock logo
RELV
Reliv' International
$3.85
$3.51
$2.50
$4.42
$6.72M-0.123,200 shsN/A
XTLB
XTL Biopharmaceuticals
$2.56
-1.2%
$3.99
$1.73
$6.69
$13.95M1.21200,233 shs33,017 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
+4.56%-9.19%-23.98%+22.93%+28.24%
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
-13.24%-9.23%-11.94%-1.67%+84.38%
Reliv' International, Inc. stock logo
RELV
Reliv' International
0.00%+1.32%-3.75%-2.04%+5.48%
XTLB
XTL Biopharmaceuticals
-1.16%+3.64%-8.90%+212.20%+109.82%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
0.8463 of 5 stars
3.50.00.00.01.60.80.6
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/AN/AN/AN/AN/A
Reliv' International, Inc. stock logo
RELV
Reliv' International
N/AN/AN/AN/AN/AN/AN/AN/A
XTLB
XTL Biopharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
3.00
Buy$24.00376.19% Upside
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/A
Reliv' International, Inc. stock logo
RELV
Reliv' International
N/AN/AN/AN/A
XTLB
XTL Biopharmaceuticals
N/AN/AN/AN/A

Current Analyst Ratings

Latest XTLB, CAPR, ETST, and RELV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/1/2024
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$40.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
$25.18M6.31N/AN/A$0.73 per share6.90
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$50K365.78N/AN/AN/A
Reliv' International, Inc. stock logo
RELV
Reliv' International
$35.06M0.19$0.09 per share44.53$6.36 per share0.61
XTLB
XTL Biopharmaceuticals
N/AN/AN/AN/A$0.73 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
-$22.29M-$0.87N/A42.00N/A-88.52%-299.67%-45.54%5/9/2024 (Estimated)
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
-$370KN/A0.00N/A5.77%20.61%11.73%N/A
Reliv' International, Inc. stock logo
RELV
Reliv' International
-$440KN/AN/AN/A-0.61%-1.89%-1.31%N/A
XTLB
XTL Biopharmaceuticals
-$1.35M-$0.42N/AN/AN/A-73.05%-68.83%5/21/2024 (Estimated)

Latest XTLB, CAPR, ETST, and RELV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/29/2024Q4 2023
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
-$0.23-$0.02+$0.21-$0.02$5.80 million$12.09 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
N/AN/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/AN/A
Reliv' International, Inc. stock logo
RELV
Reliv' International
N/AN/AN/AN/AN/A
XTLB
XTL Biopharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
N/A
1.63
1.63
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
0.10
0.87
0.39
Reliv' International, Inc. stock logo
RELV
Reliv' International
0.05
1.70
1.04
XTLB
XTL Biopharmaceuticals
N/A
14.09
N/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
21.68%
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/A
Reliv' International, Inc. stock logo
RELV
Reliv' International
7.95%
XTLB
XTL Biopharmaceuticals
4.40%

Insider Ownership

CompanyInsider Ownership
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
12.00%
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
24.90%
Reliv' International, Inc. stock logo
RELV
Reliv' International
31.18%
XTLB
XTL Biopharmaceuticals
29.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
N/A31.50 million27.72 millionOptionable
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
8309.98 million232.80 millionNot Optionable
Reliv' International, Inc. stock logo
RELV
Reliv' International
911.75 millionN/ANot Optionable
XTLB
XTL Biopharmaceuticals
N/A5.45 million3.87 millionNot Optionable

XTLB, CAPR, ETST, and RELV Headlines

SourceHeadline
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.03%U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.03%
msn.com - March 20 at 8:50 PM
US Stocks Edge Lower Ahead Of Feds Decision; General Mills Earnings Top ViewsUS Stocks Edge Lower Ahead Of Fed's Decision; General Mills Earnings Top Views
msn.com - March 20 at 3:48 PM
Dow Surges 350 Points; Fed Holds Rates SteadyDow Surges 350 Points; Fed Holds Rates Steady
markets.businessinsider.com - March 20 at 3:48 PM
Crude Oil Surges 2%; Signet Jewelers Shares Spike HigherCrude Oil Surges 2%; Signet Jewelers Shares Spike Higher
markets.businessinsider.com - March 20 at 3:48 PM
XTL To Aquire The Social ProxyXTL To Aquire The Social Proxy
globenewswire.com - March 20 at 10:15 AM
XTL Biopharmaceuticals Ltd ADR (XTLB)XTL Biopharmaceuticals Ltd ADR (XTLB)
investing.com - February 17 at 10:28 AM
Call for ProposalsCall for Proposals
raps.org - February 11 at 2:00 PM
XTL Biopharmaceuticals Ltd (H2K2.MU)XTL Biopharmaceuticals Ltd (H2K2.MU)
finance.yahoo.com - October 23 at 11:13 PM
XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyXTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
finanznachrichten.de - October 23 at 12:16 AM
XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in IsraelXTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel
finanznachrichten.de - October 21 at 8:22 AM
XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in IsraelXTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel
finance.yahoo.com - October 20 at 7:35 PM
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyXTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
finance.yahoo.com - October 20 at 7:35 PM
Is X T L Biopharmaceuticals Ltd (ADR) (XTLB) Stock a Good Investment?Is X T L Biopharmaceuticals Ltd (ADR) (XTLB) Stock a Good Investment?
aaii.com - March 30 at 3:19 PM
XTLB XTL Biopharmaceuticals Ltd.XTLB XTL Biopharmaceuticals Ltd.
seekingalpha.com - October 1 at 8:47 PM
X T L Biopharmaceuticals LtdX T L Biopharmaceuticals Ltd
reuters.com - August 8 at 10:32 PM
LIFE, TBLT and XTLB among pre market gainersLIFE, TBLT and XTLB among pre market gainers
seekingalpha.com - July 23 at 7:53 AM
XTL Biopharmaceuticals Year to Date Total Returns (Daily)XTL Biopharmaceuticals Year to Date Total Returns (Daily)
ycharts.com - December 18 at 11:24 PM
XTL Biopharmaceuticals Dividend Per Share (TTM)XTL Biopharmaceuticals Dividend Per Share (TTM)
ycharts.com - December 18 at 1:03 AM
XTL Biopharmaceuticals Ltd. (XTLB)XTL Biopharmaceuticals Ltd. (XTLB)
uk.finance.yahoo.com - December 15 at 10:18 AM
X.T.L. Biopharmaceuticals Ltd. - ADRX.T.L. Biopharmaceuticals Ltd. - ADR
money.usnews.com - September 26 at 12:03 AM
XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) Up 1.8% This Year: What Should You Expect Next?XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) Up 1.8% This Year: What Should You Expect Next?
stocksregister.com - August 23 at 4:44 PM
Is XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) Expensive At $4.67? Here’s How To Know.Is XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) Expensive At $4.67? Here’s How To Know.
marketingsentinel.com - August 20 at 5:09 PM
How Is XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) Expected To Fare In The Coming Months?How Is XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) Expected To Fare In The Coming Months?
marketingsentinel.com - July 26 at 9:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Capricor Therapeutics logo

Capricor Therapeutics

NASDAQ:CAPR
Capricor Therapeutics, Inc. (NASDAQ:CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. Capricor's lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy. Capricor has also established itself as one of the leading companies investigating the field of extracellular vesicles and is exploring the potential of CAP-2003, a cell-free, exosome-based candidate, to treat a variety of disorders.
Earth Science Tech logo

Earth Science Tech

OTCMKTS:ETST
Earth Science Tech, Inc. focuses on health and wellness industry. It operates men's health telemedicine platform under brand Peak name; and operates pharmacy. The company offers supplements and topicals products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.
Reliv

Reliv' International

NASDAQ:RELV
Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.

XTL Biopharmaceuticals

NASDAQ:XTLB
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.